Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients

Table 4 Demographic data of 173 inflammatory bowel diseases patients included in the association analysis

Characteristics	Crohn’s disease	Ulcerative colitis	All
Patients	84 (49%)	89 (51%)	173 (100%)
Age (documented for 171 individuals)	37.5 (± 15.3)	41.7 (± 14.2)	39.7 (± 14.9)
mean ± SD	35	42	39
Median	16	18	16
Minimum	72	82	82
Maximum
Known GC treatment outcome in the past	50	50	100
No. of patients currently treated with GCs	83	60	143
Male/female	52 (58.4%)/ 37 (41.6%)	40 (47.6%)/ 44 (52.4%)	92 (53.2%)/ 81 (46.8%)
Wild-type carriers	15 (16.9%)	20 (23.8%)	35 (20.2%)
Carriers of one variant haplotype	48 (53.9%)	39 (46.4%)	87 (50.3%)
Carriers of two variant haplotypes	26 (29.2%)	25 (29.8%)	51 (29.5%)

GCs: Glucocorticoids.